Synchrotron microbeam radiotherapy evokes a different early tumor immunomodulatory response to conventional radiotherapy in EMT6.5 mammary tumors
Background: Synchrotron microbeam radiation therapy (MRT) is a new, evolving form of radiotherapy that has potential for clinical application. Several studies have shown in preclinical models that synchrotron MRT achieves equivalent tumor control to conventional radiotherapy (CRT) but with significa...
| Published in: | Radiotherapy and Oncology |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier Ireland Ltd
2019
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060246825&doi=10.1016%2fj.radonc.2019.01.006&partnerID=40&md5=3c029f14cbd1717791f70269f16f6309 |